Latest Diabetes: Type II news
ERA: Semaglutide Improves Health-Related QoL in Adults With T2D, CKD
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ERA: Dihydropyridine Calcium-Channel-Blockers Tied to Higher Risk for Kidney Disease Progression in T2D
posted June 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Oral Orforglipron Noninferior, Superior to Oral Semaglutide for T2DM
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide May Increase Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
posted February 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
